DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Foley SR, Webert K, Arnold DM. et al.
A Canadian phase II study evaluating the efficacy
of rituximab in the management of patients with relapsed/refractory
thrombotic thrombocytopenic purpura.
Kidney Int 2009; 75 (Suppl. 112) S55-S58
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.